The project of extracting a new vaccine adjuvant from 'Ashwagandha'(Withania somnifera), a medicinal plant used in Ayurveda as an immunity enhancer, was sponsored by the Department of Science and Technology and was jointly executed by the researchers from
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
The Indian gensing ‘Ashwagandha,’ gets US patent for vaccine adjuvant
- Singh & Associates
- India, USA
- August 31 2013
To view this article you need a PDF viewer such as Adobe Reader.
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.